News & Articles

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Which new products made the most difference to your lab work this year?

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need

Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts